DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New Content Coverage for 2017

IN 2017, DRG IS EXPANDING OUR DISEASE COVERAGE AND GEOGRAPHIC BREADTH. BELOW IS THE LIST OF BRAND NEW CONTENT THAT WILL BECOME AVAILABLE IN 2017.

AUTOIMMUNE AND INFLAMMATION

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
ACUTE RESPIRATORY DISTRESS US/EU5 Niche and Rare
Disease
Landscape and Forecast
ASTHMA US Current Treatment
ASTHMA Nucala Mepolizumab (Wave 3) EU5 Emerging Therapies
ATOPIC DERMATITIS EU5 Access and Reimbursement
ATOPIC DERMATITIS US Access and Reimbursement
ATOPIC DERMATITIS Crisaborole (Wave 1) US Emerging Therapies
ATOPIC DERMATITIS Crisaborole (Wave 2) US Emerging Therapies
ATOPIC DERMATITIS Crisaborole (Wave 3) US Emerging Therapies
ATOPIC DERMATITIS Dupilumab (Wave 1) US Emerging Therapies
ATOPIC DERMATITIS Dupilumab (Wave 2) US Emerging Therapies
ATOPIC DERMATITIS US/EU5 Unmet Need
AXIAL SPONDYLOARTHRITIS Nucala Mepolizumab (Wave 3) US Current Treatment
CHRONIC OBSTRUCTIVE PULMONARY DISEASE EU5 Current Treatment
CHRONIC OBSTRUCTIVE PULMONARY DISEASE US Current Treatment
COPD & ASTHMA Salmeterol/Fluticasone Generic (Wave 1) US Emerging Therapies
COPD & ASTHMA Salmeterol/Fluticasone Generic (Wave 2) US Emerging Therapies
COPD & ASTHMA G7 Special Topics
COPD FF/UMEC/VI (Wave 1) US Emerging Therapies
CROHN'S DISEASE Adult US Current Treatment
CROHN'S DISEASE Pediatric US Current Treatment
CROHN'S DISEASE EU5 Current Treatment
IDIOPATHIC PULMONARY FIBROSIS ROW Epidemiology
IRRITABLE BOWEL SYNDROME US/EU5 Unmet Need
PRIMARY BILIARY CHOLANGITIS G7 Epidemiology
PRIMARY BILIARY CHOLANGITIS US/EU5 Niche and Rare
Disease
Landscape and Forecast
PSORIASIS EU5 Access and Reimbursement
PSORIASIS US Access and Reimbursement
PSORIASIS US Current Treatment
PSORIATIC ARTHRITIS EU5 Current Treatment
PSORIATIC ARTHRITIS US Current Treatment
RHEUMATOID ARTHRITIS & PSORIATIC ARTHRITIS Indication-Specific Pricing US Access and Reimbursement
RHEUMATOID ARTHRITIS EU5 Access and Reimbursement
SYSTEMIC LUPUS ERYTHEMATOSUS US Current Treatmentt
SYSTEMIC LUPUS ERYTHEMATOSUS Lupus Nephritis US/EU5 Unmet Need
ULCERATIVE COLITIS & CROHN'S DISEASE Brazil/ Mexico Access and Reimbursement
ULCERATIVE COLITIS & CROHN'S DISEASE US Access and Reimbursement
ULCERATIVE COLITIS EU5 Current Treatment
ULCERATIVE COLITIS US Current Treatment
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

BIOSIMILARS

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
BIOSIMILARS Immunology /Infliximab Wave 1 US Emerging Biosimilars
BIOSIMILARS Immunology /Infliximab Wave 2 US Emerging Biosimilars
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

CARDIOVASCULAR

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
ACUTE CORONARY SYNDROME Accountable Care Organiza- tions US Access and Reimbursement
ACUTE CORONARY SYNDROME US Current Treatment
ACUTE HEART FAILURE US Current Treatment
ATRIAL FIBRILLATION US Current Treatment
ATRIAL FIBRILLATION Disease Landscape and Forecast
HEART FAILURE Acute Heart Failure US/EU5 Unmet Need
PERIPHERAL ARTERIAL DISEASE E7 Epidemiology
PERIPHERAL ARTERIAL DISEASE ROW Epidemiology
PULMONARY HYPERTENSION US Current Treatment
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

CENTRAL NERVOUS SYSTEM

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
ACUTE PAIN Post-Operative Pain US Access and Reimbursement
ALZHEIMER'S DISEASE EU5 Access and Reimbursement
ALZHEIMER'S DISEASE Agitation in Alzheimer's Disease US/EU5 Unmet Need
CHRONIC FATIGUE SYNDROME G7 Epidemiology
CHRONIC PAIN US Access and Reimbursement
EPILEPSY G7 Disease Landscape and Forecast
EPILEPSY Dravet Syndrome US/EU5 Unmet Need
MIGRAINE Migraine Prophylaxis US Current Treatment
MIGRAINE CGRP Inhibitors US Special Topics
MULTIPLE SCLEROSIS Ocrelizumab in Relapsing-Remitting in MS (Wave 1) US Emerging Therapies
MULTIPLE SCLEROSIS US Access and Reimbursement
MULTIPLE SCLEROSIS Ocrelizumab in PP-MS (Wave 1) US Emerging Therapies
MULTIPLE SCLEROSIS Zinbryta (Wave 2) US Emerging Therapies
MULTIPLE SCLEROSIS Zinbryta (Wave 3) US Emerging Therapies
NEUROPATHIC PAIN Painful Diabetic Neuropathy US/EU5 Unmet Need
OPIOD ADDICTION US/EU5 Disease Landscape and Forecast
OSTEOARTHRITIC PAIN US Current Treatment
OSTEOARTHRITIC PAIN G7 Disease Landscape and Forecast
OSTEOARTHRITIC PAIN US/EU5 Unmet Need
PARKINSON'S DISEASE EU5 Current Treatment
PARKINSON'S DISEASE Adjunctive Therapies for Motor Response Complications US/EU5 Unmet Need
POST-OPERATIVE PAIN US Current Treatment
SCHIZOPHRENIA Depot Antipsychotic Use US Access and Reimbursement
SCHIZOPHRENIA US Access and Reimbursement
SCHIZOPHRENIA EU5 Current Treatment
UNIPOLAR DEPRESSION Depot Antipsychotic Use US Access and Reimbursement
UNIPOLAR DEPRESSION EU5 Current Treatment
UNIPOLAR DEPRESSION Treatment Resistant Depression US/EU5 Unmet Need
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

HEMATOLOGY

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
HEREDITARY ANGIOEDEMA E7 Epidemiology
HEMOPHILIA E7 Epidemiology
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

INFECTIOUS DISEASES

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
CLOSTRIDIUM DIFFICILE INFECTIONS US/EU5 Niche and Rare
Disease
Landscape and Forecast
EMERGING VACCINES G7 Disease Landscape and Forecast
EMERGING VACCINES G7 Epidemiology
GRAM-NEGATIVE INFECTIONS EU5 Access and Reimbursement
HEPATITIS B VIRUS US/EU5 Niche and Rare
Disease
Landscape and Forecast
HEPATITIS C VIRUS Mexico/ Argentina Access and Reimbursement
HEPATITIS C VIRUS ROW Epidemiology
HOSPITAL-TREATED INFECTIONS China Access and Reimbursement
HUMAN IMMUNODEFICIENCY VIRUS E7 Epidemiology
HUMAN IMMUNODEFICIENCY VIRUS ROW Epidemiology
METHICILLIN-RESISTANT STAPHYLOCCOCUS AUREUS (MRSA) Bone and Joint infections US/EU5 Unmet Need
METHICILLIN-RESISTANT STAPHYLOCCOCUS AUREUS INFECTIONS (MRSA) Outpatient Parenteral Antibiotic Therapy (OPAT) US Current Treatment
SEPSIS US/EU5 Niche and Rare
Disease
Landscape and Forecast
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

NICHE AND RARE DISEASES

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
ORPHAN DRUGS Latin America Access and Reimbursement
RARE DISEASES Gene Therapies US/EU5 Special Topics
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

METABOLIC-RENAL

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
DIABETIC NEPHROPATHY US Current Treatment
DIABETIC NEPHROPATHY G7 Disease Landscape and Forecast
DIABETIC NEPHROPATHY US/EU5 Unmet Need
HYPERKALEMIA US Current Treatment
HYPERKALEMIA G7 Disease Landscape and Forecast
HYPERKALEMIA G7 Epidemiology
MALE HYPOGONADISM (LOW TESTOSTERONE) US/EU5 Niche and Rare
Disease
Landscape and Forecast
NON-ALCOHOLIC STEATOHEPATITIS (NASH) E7 Epidemiology
NON-ALCOHOLIC STEATOHEPATITIS (NASH) ROW Epidemiology
NON-ALCOHOLIC STEATOHEPATITIS (NASH) US/EU5 Unmet Need
OBESITY/OVERWEIGHT US Current Treatment
OBESITY/OVERWEIGHT ROW Epidemiology
OBESITY/OVERWEIGHT US/EU5 Unmet Need
OSTEOPOROSIS US Access and Reimbursement
OSTEOPOROSIS abaloparatide, romosozumab and oral salmon calcitonin (Wave 1) US Emerging Therapies
RENAL ANEMIA G7 Disease Landscape and Forecast
TYPE 1 DIABETES G7 Disease Landscape and Forecast
TYPE 1 DIABETES ROW Epidemiology
TYPE 2 DIABETES China Access and Reimbursement
TYPE 2 DIABETES Latin America Access and Reimbursement
TYPE 2 DIABETES EU5 Current Treatment
TYPE 2 DIABETES US Current Treatment
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

ONCOLOGY

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
BIOGEOGRAPHYERS IN ONCOLOGY US Access and Reimbursement
BLADDER CANCER US/EU5 Unmet Need
BREAST CANCER Brazil/ Mexico Access and Reimbursement
BREAST CANCER EU5 Access and Reimbursement
BREAST CANCER The influence of value assessment models on clinical pathways US Access and Reimbursement
BREAST CANCER US Current Treatment
CHRONIC MYELOID LEUKEMIA US Current Treatment
COLORECTAL CANCER EU5 Access and Reimbursement
GASTRIC CANCER, GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA AND ESOPHAGEAL CANCER G7 Disease Landscape and Forecast
HEMATOLOGICAL MALIGNANCIES US Access and Reimbursement
IMMUNE CHECKPOINT INHIBITORS EU5 Access and Reimbursement
IMMUNE CHECKPOINT INHIBITORS US Access and Reimbursement
MALIGNANT MELANOMA EU5 Access and Reimbursement
MALIGNANT MELANOMA US Current Treatment
MULTIPLE MYELOMA US Access and Reimbursement
MULTIPLE MYELOMA Darzalex/Empliciti (Wave 3) US Emerging Therapies
MULTIPLE MYELOMA ROW Epidemiology
NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T (Wave 1) US Emerging Therapies
NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T (Wave 2) US Emerging Therapies
NON-HODGKIN'S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA Venetoclax (Wave 3) US Emerging Therapies
NON-SMALL-CELL LUNG CANCER Brazil/ Mexico Access and Reimbursement
OVARIAN AND ENDOMETRIAL CANCER US Access and Reimbursement
OVARIAN CANCER US/EU5 Unmet Need
PANCREATIC CANCER ROW Epidemiology
PANCREATIC CANCER US/EU5 Unmet Need
PROSTATE CANCER EU5 Current Treatment
RENAL CELL CARCINOMA EU5 Access and Reimbursement
RENAL CELL CARCINOMA Implications of physician- dispensing of oral oncolytics for renal cell carcinoma US Access and Reimbursement
RENAL CELL CARCINOMA US Current Treatment
SUPPORTIVE CARE IN ONCOLOGY US Access and Reimbursement
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

OPHTHALMOLOGY

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
AGE-RELATED MACULAR DEGENERATION EU5 Access and Reimbursement
AGE-RELATED MACULAR DEGENERATION US Access and Reimbursement
AGE-RELATED MACULAR DEGENERATION Geographic Atrophy US/EU5 Unmet Need
RETINITIS PIGMENTOSA G7 Epidemiology
RETINITIS PIGMENTOSA US/EU5 Niche and Rare
Disease
Landscape and Forecast
DISEASE CONTENT DETAIL GEOGRAPHY MODULE

 

WOMEN’S HEALTH

DISEASE CONTENT DETAIL GEOGRAPHY MODULE
ENDOMETRIOSIS G7 Epidemiology
ENDOMETRIOSIS US/EU5 Niche and Rare
Disease
Landscape and Forecast
UTERINE FIBROIDS US/EU5 Niche and Rare
Disease
Landscape and Forecast
UTERINE FIBROIDS US/EU5 Niche and Rare
Disease
Landscape and Forecast
UTERINE FIBROIDS G7 Epidemiology
DISEASE CONTENT DETAIL GEOGRAPHY MODULE